Franciscan Saint Francis Health-Indianapolis

Indianapolis, Indiana 46237

0 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma of the Gastroesophageal Junction, Adult Angiosarcoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Cancer, Cervical Squamous Cell Carcinoma, Diffuse Gastric Adenocarcinoma, Esophageal Cancer, Gastric Cancer, Gastric Intestinal Type Adenocarcinoma, Gastric Mixed Adenocarcinoma, Gastrinoma

Studies at this site

• Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma — Stopped early
• Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors — Running, not enrolling
• Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy — Completed
• S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer — Completed
• Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer — Completed
• Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery — Completed
• Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy — Completed
• Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer — Completed
• Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery — Completed